Rheumatological mimickers of HIV infection. Part 2: Multisystem involvement
https://doi.org/10.14412/1996-7012-2025-6-13-18
Abstract
The second part of the lecture is devoted to the issues of differential diagnosis of certain immune-inflammatory rheumatic diseases and syndromes directly associated with HIV infection, with an emphasis on immune reconstitution inflammatory syndrome during antiretroviral therapy, the differential diagnosis of Sjögren’s syndrome and diffuse interstitial lymphocytic syndrome, and the manifestation of systemic lupus erythematosus in HIV infection. Modern classification of muscle involvement and issues of vasculitis pathogenesis in HIV-infected patients are considered.
Keywords
immunosuppressive therapy,
antirheumatic drugs,
HIV infection,
rheumatic diseases,
diffuse interstitial lymphocytic syndrome,
immune reconstitution inflammatory syndrome,
antiretroviral therapy
Supporting agencies: This article was prepared within the framework of the research project (state assignment №PK 125020301268-4)
About the Authors
G. I. Gridneva
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
Galina Igorevna Gridneva
34A, Kashirskoe Shosse, Moscow 115522
B. S. Belov
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522
E. S. Aronova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522
M. S. Tolbeeva
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522
References
1. Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984 May; 224(4648):500-3. doi: 10.1126/science.6200936.
2. Gridneva GI, Belov BS. Current issues in the management of patients with HIV infection and rheumatic diseases. Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2021;15(6): 7-12. (In Russ.). doi: 10.14412/1996-7012-2021-6-7-12.
3. Zhang X, Li H, Li T, et al. Distinctive rheumatic manifestations in 98 patients with human immunodeficiency virus infection in China. J Rheumatol. 2007 Aug;34(8):1760-4.
4. Christoforidou A, Galanopoulos N. Diffuse connective tissue disorders in HIV-infected patients. Mediterr J Rheumatol. 2018 Sep;29(3): 148-55. doi:10.31138/mjr.29.3.148.
5. Kravchenko AV, Yurin OG, Belyaeva VV, Pokrovskiy VV. Treatment of HIV infection in the Russian Federation. Terapevticheskii arkhiv. 2009;81(4):64-8. (In Russ.).
6. Marquez J, Restrepo CS, Candia L, et al. Human immunodeficiency virus-associated rheumatic disorders in the HAART era. J Rheumatol. 2004 Apr;31(4):741-6.
7. Calabrese LH, Kirchner E, Shrestha R. Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease. Semin Arthritis Rheum. 2005 Dec;35(3):166-74. doi:10.1016/j.semarthrit.2005.03.007.
8. Yang JJ, Tsai MS, Sun HY, et al. Autoimmune diseases-related arthritis in HIV-infected patients in the era of highly active antiretroviral therapy. J Microbiol Immunol Infect. 2015 Apr; 48(2):130-6. doi: 10.1016/j.jmii.2013.08.002.
9. Boeva EV, Belyakov NA. Immune reconstitution inflammatory syndrome. Infektsiya i immunitet. 2018;8(2):139-49. (In Russ.).
10. Cherif I, Tsevi YM, Bawe LD, et al. Efficacy of highly active antiretroviral therapy alone in the treatment of diffuse lymphocytic infiltration syndrome in an ivorian patient living with HIV: a case report. Med Trop Sante Int. 2021 Aug 20; 1(3):mtsibulletin.2021.118. doi: 10.48327/mtsibulletin.2021.118.
11. Oksenhendler E, Autran B, Gorochov G, et al. CD8 lymphocytosis and pseudotumoral splenomegaly in HIV infection. Lancet. 1992 Jul; 340(8813):207-8. doi: 10.1016/0140-6736(92)90471-e.
12. Pedaprolu AS, Jajoo S, Mahakalkar C, et al. Navigating Parotid Lymphoepithelial Cysts in HIV Patients: A Tale of Two Distinct Scenarios. Cureus. 2023 Dec;15(12): e50399. doi:10.7759/cureus.50399.
13. Tripathi AK, Gupta N, Ahmad R, et al. HIV disease presenting as parotid lymphoepithelial cysts: a presumptive diagnosis of diffuse infiltrative lymphocytic syndrome (DILS). J Assoc Physicians India. 2004 Nov;52:921-3.
14. Ghrenassia E, Martis N, Boyer J, et al. The diffuse infiltrative lymphocytosis syndrome (DILS). A comprehensive review. J Autoimmun. 2015 May;59:19-25. doi: 10.1016/j.jaut.2015.01.010.
15. Vargas PA, Mauad T, Böhm GM, et al. Parotid gland involvement in advanced AIDS. Oral Dis. 2003 Mar;9(2):55-61. doi: 10.1034/j.1601-0825.2003.02868.x.
16. Liao Y, Li YJ, Hu XW, et al. Benign lymphoepithelial cyst of parotid gland without human immunodeficiency virus infection: A case report. World J Clin Cases. 2023 Feb;11(4):931-7. doi:10.12998/wjcc.v11.i4.931.
17. Sekikawa Y, Hongo I. HIV-associated benign lymphoepithelial cysts of the parotid glands confirmed by HIV-1 p24 antigen immunostaining. BMJ Case Rep. 2017 Sep;2017: bcr2017221869. doi:10.1136/bcr-2017-221869.
18. Mandel L, Hong J. HIV-associated parotid lymphoepithelial cysts. J Am Dent Assoc. 1999 Apr;130(4):528-32. doi:10.14219/jada.archive.1999.0247
19. Joshi J, Shah S, Agarwal D, Khasgiwal A. Benign lymphoepithelial cyst of parotid gland: Review and case report. J Oral Maxillofac Pathol. 2018 Jan;22:91-7. doi:10.4103/jomfp.JOMFP_252_17.
20. Shanti RM, Aziz SR. HIV-associated salivary gland disease. Oral Maxillofac Surg Clin North Am. 2009 Aug;21(3):339-43. doi:10.1016/j.coms.2009.04.002.
21. Kuvardin ES, Grigor'eva IN, Bekhtereva IA, et al. Cellular composition of the minor salivary gland inflammatory infiltrates as an additional diagnostic criterion for primary Sjögren’s syndrome. Nauchno-prakticheskaya revmatologiya. 2021;59(4):434-41. (In Russ.).
22. Khvan YuI, Torgashina AV. The evolution of international classification criteria for Sjögren’s syndrome. Nauchno-Prakticheskaya Revmatologia. 2023;61(6):650-7. (In Russ.).
23. Blokland SLM, Hillen MR, Kruize AA, et al. Increased CCL25 and T helper cells expressing CCR9 in the salivar glands of patients with primary Sjögren’s syndrome: potential new axis in lymphoid neogenesis. Arthritis Rheumatol. 2017 Oct;69(10):2038-51. doi: 10.1002/art.40182.
24. Yang JJ, Tsai MS, Sun HY, et al. Autoimmune diseases-related arthritis in HIV-infected patients in the era of highly active antiretroviral therapy. J Microbiol Immunol Infect. 2015 Apr; 48(2):130-6. doi: 10.1016/j.jmii.2013.08.002.
25. Kanevskaya MZ. Rheumatological syndromes in HIV-infection. Klinicheskaya Meditsina. 2014;92(12):12-9. (In Russ.).
26. McArthur CP, Africa CW, Castellani WJ, et al. Salivary gland disease in HIV/AIDS and primary Sjögren's syndrome: analysis of collagen I distribution and histopathology in American and African patients. J Oral Pathol Med. 2003 Oct;32(9):544-51. doi: 10.1034/j.1600-0714.2003.00159.x.
27. Saigal R, Chakraborty A, Yadav RN, Goyal LK. Rheumatological Manifestations in HIV-Positive Patients: A Single-Center Study. Adv Ther. 2020 Oct;37(10):4336-45. doi: 10.1007/s12325-020-01470-3.
28. Насонов ЕЛ. Системная красная волчанка. В кн.: Насонов ЕЛ, редактор. Российские клинические рекомендации. Ревматология. Москва: ГЭОТАР-Медиа; 2017. С. 113. Nasonov EL. Systemic lupus erythematosus. In: Nasonov EL, editor. Russian clinical guidelines. Rheumatology. Moscow: GEOTAR-Media; 2017. P. 113.
29. Akram B, Khan M, Humphrey MB. HIVAssociated Rheumatic Diseases: A Narrative Review. J Clin Rheumatol. 2024 Mar;30(2):e42e45. doi: 10.1097/RHU.0000000000002028.
30. Lebrun D, Hentzien M, Cuzin L, et al. Epidemiology of autoimmune and in ammatory diseases in a French nationwide HIV cohort. AIDS. 2017 Sep;31(15):2159-66. doi: 10.1097/QAD.0000000000001603.
31. Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev. 2002 Dec;1(6):329-37. doi:10.1016/s1568-9972(02)00086-1.
32. Nevinsky GA. Immune Response and Production of Abzymes in Patients with Autoimmune and Neurodegenerative Diseases. Biochemistry (Mosc). 2025 Jan;90:373-400. doi: 10.1134/S0006297924604167.
33. Iordache L, Bengoufa D, Taulera O, et al. Nonorgan-specific autoantibodies in HIV-infected patients in the HAART era. Medicine (Baltimore). 2017 Mar;96(10):e6230. doi:10.1097/MD.0000000000006230.
34. Steve RJ, Alex D, Yesudhason BL, et al. Autoantibodies Among HIV-1 Infected Individuals and the Effect of Anti-Retroviral Therapy (ART) on It. Curr HIV Res. 2021;19(3):277-85. doi:10.2174/1570162X19666210217120337.
35. Tlish MM, Naatyzh ZhYu, Kuznetsova TG, Gorodin V. Features of dermatological pathology on the background of HIV-infection. Terapevticheskii arkhiv. 2019;91(11):10-4. (In Russ.).
36. Nguyen BY, Reveille JD. Rheumatic manifestations associated with HIV in the highly active antiretroviral therapy era. Curr Opin Rheumatol. 2009 Jul;21(4):404-10. doi:10.1097/BOR.0b013e32832c9d04.
37. Kawakita C, Kinomura M, Otaka N, et al. HIV-associated Immune Complex Kidney Disease with C3-dominant Deposition Induced by HIV Infection after Treatment of IgA Nephropathy. Intern Med. 2019 Oct;58(20):3001-7. doi:10.2169/internalmedicine.2439-18.
38. Naovarat BS, Reveille JD, Salazar GA, et al. Systemic lupus erythematosus in the setting of HIV-1 infection: a longitudinal analysis. Clin Rheumatol. 2020 Feb;39(2):413-8. doi:10.1007/s10067-019-04867-w.
39. Torgashina AV, Solov'ev SK. Specific features of regulatory T cells in patients with systemic lupus erythematosus. Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2018;12(4):9-15. (In Russ.). doi: 10.14412/1996-7012-2018-4-9-15.
40. Liao HY, Tao CM, Su J. Concomitant systemic lupus erythematosus and HIV infection: A rare case report and literature review. Medicine (Baltimore). 2017 Dec;96(51):e9337. doi: 10.1097/MD.0000000000009337.
41. O'Kelly B, McNally C, McConkey S, Durcan L. HIV and systemic lupus erythematosus: where immunodeficiency meets autoimmunity. Lupus. 2020 Aug;29(9):1130-2. doi:10.1177/0961203320934851.
42. Authier FJ, Chariot P, Gherardi RK. Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART). Muscle Nerve. 2005 Sep;32(3):247-60. doi: 10.1002/mus.20338.
43. Nelke C, Kleefeld F, Preusse C, et al. Inclusion body myositis and associated diseases: an argument for shared immune pathologies. Acta Neuropathol Commun. 2022 Jun;10(1):84. doi: 10.1186/s40478-022-01389-6.
44. Zell SC, Nielsen S. Clinical correlates to muscle biopsy findings in HIV patients experiencing fatigue: a case series. J Int Assoc Physicians AIDS Care (Chic). 2002 Summer;1(3): 90-4. doi:10.1177/154510970200100303.
45. Carroll MB, Holmes R. Dermatomyositis and HIV infection: case report and review of the literature. Rheumatol Int. 2011 May;31(5):673-9. doi:10.1007/s00296-009-1231-x.
46. Lloyd TE, Pinal-Fernandez I, Michelle EH, et al. Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients. Neurology. 2017 Apr;88(15):1454-60. doi:10.1212/WNL.0000000000003821.
47. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. IV: cell-mediated cytotoxicity and muscle fiber necrosis. Ann Neurol. 1988 Feb;23(2):168-73. doi:10.1002/ana.410230210.
48. Grady BPX, Nanlohy NM, van Baarle D. HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection. Immun Ageing. 2016 Mar;13:10. doi:10.1186/s12979-016-0065-0.
49. Güttsches AK, Brady S, Krause K, et al. Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis. Ann Neurol. 2017 Feb;81:227-39. doi: 10.1002/ana.248471.
50. Hedberg-Oldfors C, Lindgren U, Basu S, et al. Mitochondrial DNA variants in inclusion body myositis characterized by deep sequencing. Brain Pathol. 2021 May;31(3):e12931. doi:10.1111/bpa.12931.
51. Nogalska A, D’Agostino C, Cacciottolo M, et al. Abnormalities of mitophagy in sporadic inclusion-body myositis (s-IBM) muscle fibers. Neurology. 2014;82(10):P3.288. doi:10.1212/WNL.82.10_supplement.P3.288.
52. Lindgren U, Roos S, Hedberg Oldfors C, et al. Mitochondrial pathology in inclusion body myositis. Neuromuscul Disord. 2015; 25(4):281-8. doi:10.1016/j.nmd.2014.12.010.
53. Gardner K, Hall PA, Chinnery PF, Payne BAI. HIV treatment and associated mitochondrial pathology: review of 25 years of in vitro, animal, and human studies. Toxicol Pathol. 2014 Jul;42(5):811-22. doi:10.1177/0192623313503519.
54. Nelke C, Dziewas R, Minnerup J, et al. Skeletal muscle as potential central link between sarcopenia and immune senescence. EBioMedicine. 2019 Nov;49:381-8. doi: 10.1016/j.ebiom.2019.10.034.
55. Vega LE, Espinoza LR. Vasculitides in HIV Infection. Curr Rheumatol Rep. 2020 Aug;22(10): 60. doi:10.1007/s11926-020-00945-0.
56. Vornicu A, Obri c B, Sorohan B, et al. ANCA-associated vasculitis in a HIV-infected patient:a case-based review. BMC Nephrol. 2023 Jul;24(1):210. doi:10.1186/s12882-023-03244-9.
57. De Paoli MC, Moretti D, Scolari Pasinato CM, Buncuga MG. Henoch-Schцnlein purpura in a cocaine consumer man with HIV infection and ANCA-p positivity. Medicina (B Aires). 2016;76(4):245-8.
58. Monteiro EJ, Caron D, Balda CA, et al. Anti-glomerular basement membrane glomerulonephritis in an HIV positive patient: case report. Braz J Infect Dis. 2006 Feb;10(1):55-8. doi:10.1590/s1413-86702006000100011.
59. Gridneva GI, Belov BS, Aronova ES. HIV-infection and rheumatic diseases: the current state of the problem. VICh-infekciya i immunosupressii. 2025;17(1):7-18. (In Russ.).
Review
For citations:
Gridneva GI, Belov BS, Aronova ES, Tolbeeva MS. Rheumatological mimickers of HIV infection. Part 2: Multisystem involvement. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2025;19(6):13-18. (In Russ.) https://doi.org/10.14412/1996-7012-2025-6-13-18
Views:
59
Email this article 